Star Holdings (STHO) Declined in Q1 Without Cause
Key takeaways
- Since inception, the fund has returned ~14% gross and ~10% net per annum, surpassing the benchmark’s return of ~7% per annum.
- In its first-quarter 2026 investor letter, McIntyre Partnerships highlighted Star Holdings (NASDAQ:STHO).
- McIntyre Partnerships stated the following regarding Star Holdings (NASDAQ:STHO) in its Q1 2026 investor letter:
Star Holdings (STHO) Declined in Q1 Without Cause Soumya Eswaran Tue, June 2, 2026 at 8:18 PM GMT+7 2 min read MSTR ^RUT STHO US-based investment company, Mc Intyre Partnerships, returned -19% gross and -20% net in the first quarter of 2026 compared to the Russell 2000 Value Index’s 5% return. A copy of the letter can be downloaded here. Since inception, the fund has returned ~14% gross and ~10% net per annum, surpassing the benchmark’s return of ~7% per annum. The Q1 results were disappointing for the fund, primarily due to a significant decline in the shares of life science tools and medical device stocks, in which the fund has substantial investments, as well as specific issues related to QDEL, a company in the life science tools sector. By the end of the month, the fund’s exposure was recorded at 123% long, 27% short, and 97% net. In addition, you can check the Strategy’s top 5 holdings to determine its best picks for 2026.
In its first-quarter 2026 investor letter, McIntyre Partnerships highlighted Star Holdings (NASDAQ:STHO). Star Holdings (NASDAQ:STHO) is a real estate company that engages in non-ground lease-related businesses. On June 1, 2026, Star Holdings (NASDAQ:STHO) closed at $8.88 per share. One-month return of Star Holdings (NASDAQ:STHO) was 3.62%, and its shares gained 22.48% over the past 52 weeks. Star Holdings (NASDAQ:STHO) has a market capitalization of $107.35 million.
McIntyre Partnerships stated the following regarding Star Holdings (NASDAQ:STHO) in its Q1 2026 investor letter: